Back

Why now? mechanistically comparing factor XI inhibitors with NOACs

8 April 2024 (15:45 - 16:00)
Organised by: Logo
Congress Presentation Part of: Are we seeing a paradigm shift in anticoagulation? NOACs and factor XIa inhibitors European Heart Rhythm Association (EHRA) EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Professor Vanessa Roldan-Schilling

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)

3 More presentations in this session

Presentation thumbnail
Where we are now? balancing stroke and bleeding in atrial fibrillation
Professor G. Lip (Liverpool, GB)
Slides
Presentation thumbnail
Where are we heading? factor XI inhibitors for atrial fibrillation and stroke prevention
Professor J. Deharo (Marseille, FR)
Slides
Presentation thumbnail
What about holistic or integrated care management for atrial fibrillation?
Associate Professor M. Proietti (Milan, IT)
Slides

Access the full session

Session thumbnail
Are we seeing a paradigm shift in anticoagulation? NOACs and factor XIa inhibitors

The Event

Event poster

EHRA 2024

8 April 2024 15:45 CET
You may be interested in
thumbnail
Congress Presentation
Factor XI inhibitors or direct oral anticoagulants in atrial fibrillation: an updated meta-analysis
1 September 2025
thumbnail
Congress Session
Cardiology Toolbox: managing heparin-induced thrombocytopaenia (HIT), factor V Leiden, and antiphospholipid syndromes in cardiovascular medicine
2 September 2024
thumbnail
Congress Presentation
Early DOAC therapy after invasive acute pulmonary embolism therapy: fast track PE?
20 March 2026
thumbnail
Congress Presentation
Prior anticoagulation experience, bleeding risk, and safety of factor XI inhibition in atrial fibrillation: an analysis of AZALEA-TIMI 71
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources